Fisher, C., Dhainaut, J., Opal, S., Pribble, J., Balk, R., Slotman, G., . . . Greenman, R. (1994). Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Fisher, C., et al. Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients with Sepsis Syndrome. Results from a Randomized, Double-blind, Placebo-controlled Trial. Phase III RhIL-1ra Sepsis Syndrome Study Group. 1994.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Fisher, C., et al. Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients with Sepsis Syndrome. Results from a Randomized, Double-blind, Placebo-controlled Trial. Phase III RhIL-1ra Sepsis Syndrome Study Group. 1994.